Cargando…
BACE inhibitor treatment of mice induces hyperactivity in a Seizure-related gene 6 family dependent manner without altering learning and memory
BACE inhibitors, which decrease BACE1 (β-secretase 1) cleavage of the amyloid precursor protein, are a potential treatment for Alzheimer’s disease. Clinical trials using BACE inhibitors have reported a lack of positive effect on patient symptoms and, in some cases, have led to increased adverse even...
Autores principales: | Nash, A., Gijsen, H. J. M., Hrupka, B. J., Teng, K. S.-L., Lichtenthaler, S. F., Takeshima, H., Gunnersen, J. M., Munro, K. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302682/ https://www.ncbi.nlm.nih.gov/pubmed/34302009 http://dx.doi.org/10.1038/s41598-021-94369-0 |
Ejemplares similares
-
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
por: Pigoni, Martina, et al.
Publicado: (2016) -
Seizure-6 proteins highlight BACE1 functions in neurobiology
por: Pigoni, Martina, et al.
Publicado: (2016) -
Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
por: Munro, Kathryn M., et al.
Publicado: (2016) -
The β-Secretase Substrate Seizure 6–Like Protein (SEZ6L) Controls Motor Functions in Mice
por: Ong-Pålsson, Emma, et al.
Publicado: (2021) -
BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines
por: Blume, Tanja, et al.
Publicado: (2018)